Latest Nanotechnology News

Page 1 of 2
Dotz Nano Limited has raised approximately A$2 million through a private placement, reinforcing its position in the emerging carbon capture market with fresh capital and new investors.
Sophie Babbage
Sophie Babbage
18 Dec 2025
Dotz Nano has extended the maturity dates of key convertible notes held by Mercer Street Capital Partners, signaling sustained investor confidence in its carbon capture technology and growth plans.
Sophie Babbage
Sophie Babbage
14 Nov 2025
Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.
Ada Torres
Ada Torres
31 Oct 2025
Adisyn Ltd has strengthened its position in semiconductor innovation by commissioning a cutting-edge Atomic Layer Deposition system, accelerating its graphene interconnect development while maintaining a robust cash reserve.
Sophie Babbage
Sophie Babbage
30 Oct 2025
Dotz Nano Limited has raised an additional A$460,000 through unsecured loans, bringing total funding under this facility to A$1.2 million to support working capital needs.
Sophie Babbage
Sophie Babbage
7 Oct 2025
Dotz Nano has secured its first commercial order for its innovative Amine-Modified Polymer CO2 sorbent from a leading automotive innovation hub, marking a key step toward commercial deployment in sustainable aviation fuel production.
Sophie Babbage
Sophie Babbage
30 Sept 2025
Dotz Nano Limited has raised approximately A$740,000 through unsecured loans featuring convertible options, aiming to bolster its working capital amid ongoing funding efforts.
Sophie Babbage
Sophie Babbage
9 Sept 2025
Dotz Nano has responded to an ASX price query following unusual trading activity, confirming no undisclosed information and reaffirming compliance with continuous disclosure rules.
Sophie Babbage
Sophie Babbage
2 Sept 2025
Dotz Nano Limited reported a reduced half-year loss and significant progress in its Direct Air Capture technology, while navigating funding uncertainties with key investors.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Imagion Biosystems reported a $1.66 million loss for the half-year ending June 2025 while progressing its MagSense® HER2 Imaging Agent towards a Phase 2 FDA trial and securing $3.5 million in new funding.
Ada Torres
Ada Torres
27 Aug 2025
Locksley Resources has partnered with Rice University to pioneer domestic antimony processing in the US, aiming to reduce reliance on foreign supply and support critical defense and energy sectors.
Maxwell Dee
Maxwell Dee
25 Aug 2025
Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.
Ada Torres
Ada Torres
4 Aug 2025